Xarelto® Dosing Guide

Stroke Prevention in Atrial Fibrillation1

Xarelto Dosing Guide - Stroke Prevention in Atrial FibrillationXarelto Dosing Guide - Stroke Prevention in Atrial Fibrillation

Pulmonary Embolism and Deep Vein Thrombosis1

Xarelto Dosing Guide - Pulmonary Embolism and Deep Vein ThrombosisXarelto Dosing Guide - Pulmonary Embolism and Deep Vein Thrombosis

Prevention of Atherothrombotic Events1

Xarelto Dosing Guide - Prevention of Atherothrombotic EventsXarelto Dosing Guide - Prevention of Atherothrombotic Events

Prevention of VTE in Adults Undergoing Elective Hip or Knee Surgery1

Xarelto Dosing Guide - Prevention of VTE in Adults Undergoing Elective Hip or Knee SurgeryXarelto Dosing Guide - Prevention of VTE in Adults Undergoing Elective Hip or Knee Surgery

Secondary Prevention after ACSd,1

Dosing Guide Secondary Prevention after ACS Twice daily XareltoDosing Guide Secondary Prevention after ACS Twice daily Xarelto

Dosing Guide

Xarelto 15 mg and 20 mg should be taken with food
Xarelto 15 mg and 20 mg should be taken with food.
Xarelto 2.5 mg and 10 mg can be taken with or without food.

a Use with caution when patient is concomitantly receiving other medicinal products that increase rivaroxaban plasma concentration.
b Not recommended in patients with CrCl <15 ml/min; use with caution in patients with CrCl 15–29 ml/min and in patients with CrCl 30–49 ml/min when concomitantly receiving other medicinal products that increase rivaroxaban plasma concentration.
c In patients with CrCl 15–49 ml/min 15 mg OD should be considered if the patient’s assessed risk of bleeding outweighs the risk of recurrent PE/DVT.
d In combination with standard antiplatelet therapy of ASA alone or ASA in combination with clopidogrel or ticlopidine, in adults with elevated cardiac biomarkers: Troponin-I/T; creatine kinase-muscle and brain isoenzyme (CK-MB).
e 75-100 mg OD.